companydata.dkPerfusion Tech ApS: Financial statements 2022
CVR: 38238213
Perfusion Tech ApS (CVR 38238213) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -4,201,186 and a net result of DKK -6,556,178 compared with DKK -2,117,687 the year before. Equity amounted to DKK 1,169,653. The solvency ratio was 23.9%. The company had 7 employees in the financial year.
- Gross Profit
- -4,201,186 kr.
- Profit/Loss
- -6,556,178 kr.
- Equity
- 1,169,653 kr.
- Total Assets
- 4,887,954 kr.
- Employees
- 7
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -4.2 mio. | -6.6 mio. | 1.2 mio. | 7 |
| 2021 | - | -1.1 mio. | -2.1 mio. | -3.9 mio. | 4 |
| 2020 | - | -1.1 mio. | -1.5 mio. | -1.8 mio. | 3 |
| 2019 | - | -539 t. | -596 t. | -329 t. | 1 |
| 2018 | - | -262 t. | -238 t. | -453 t. | - |
Keep an eye on Perfusion Tech ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of October 24, 2022, Sten Scheibye has joined the board of directors of Perfusion Tech ApS.
As of October 24, 2022, Mads Aagaard Linde Madsen has left the board of directors of Perfusion Tech ApS.
As of October 1, 2022, Pernille Charlotte Singer is registered as director of Perfusion Tech ApS.
Perfusion Tech ApS has published its annual report for 2021. Gross profit came to DKK -1,066,804, and the net result was DKK -2,117,687.
As of March 21, 2022, Henrik Christensen has joined the board of directors of Perfusion Tech ApS.
About Perfusion Tech ApS
Perfusion Tech ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Perfusion Tech IVS. The management consists of Declan Cassells. The company is owned by Renew Pharmaceuticals Limited. In 2025, the company reported a gross profit of DKK -6,142,804 and a net result of DKK -12,724,708 compared with DKK -14,469,520 the year before. Equity amounted to DKK -9,640,655.